Test for STDs, UTIs, and more in
the comfort of your home!
Fidalab Contract Research Service
Services we provide: specimen collection kits, donor screening test, critical reagent generation and qualification, stability and sterility-testing, and more!
We provide real time PCR-based testing for the SARS-CoV-2 virus, which provides the highest sensitivity and specificity for COVID-19 detection.
Our PCR-based urinary tract pathogen detection is faster and 3x more sensitive compared to standard urine culture.
Because of similar symptoms displayed by COVID-19, flu, and other respiratory tract infections, molecular testing is the gold standard for differential diagnosis. Our URI panel test detects 22 common upper respiratory infectious organisms, including influenza and RSV.
PCR-based pathogen detection provides a comprehensive molecular diagnostic tool for women’s health related issues, ranging from cervical cancer screening to STI screening, and urinary tract infection.
PCR-based wound infection pathogen detection is a superior method to the standard culture-based method. Simultaneous antibiotic resistance gene detection improves turn-around time, and assists in providing timely, individualized, and effective treatment for wound infection.
FidaLab is a pioneer in the clinical Histopathology evaluation of chronic wounds. Currently, most such work is investigational on animal models in research.
Chronic wound is a prevalent health issue in the elderly population. Although wound healing is powerfully programed during evolution, it can be derailed by a variety of host and local factors. Diagnosing atypical wounds such as Marjolin ulcers or vasculitides leads to effective targeted therapy. For “typical wounds”, assessment of the wound healing progression helps identify why the wound healing process is stalled. Histopathology is also a quick way of establishing the presence of osteomyelitis in 1-2 days comparing to the lengthy scheduling of imaging studies.
Noninvasive quantitative test for HPV 16 and 18, the two HPV types associated with oropharyngeal cancer using real time PCR technology.
Our periodontal pathogen tests detects 29 bacterial species associated with periodontal disease. This test predicts progression risk of gingivitis, monitors the treatment efficacy for periodontitis, and predicts the risk of peri-implant diseases.
Our cariogenic pathogen test not only detects the presence of 8 cariogenic bacteria species but also provides the quantity of each bacteria detected. This test identifies individuals who are at increased risk of developing cavities.
Our test detects 4 Candida species including Candida albicans, Candida glabrata, Candida dubliniensis, and Candida parapsilosis.
Our oral sexually transmitted disease test detects 22 sexually transmitted pathogens.
Our herpesvirus test detects 4 herpesviruses.